FDA - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Time on MSN · 10h

FDA Approves the First Non-Opioid Pain Drug in 20 Years

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.

Newsweek on MSN · 9h

What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Ozempic receives FDA nod for treating chronic kidney disease

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

U.S. News & World Report · 1d

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh

Hosted on MSN · 1d

Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug, showed a reduced risk of kidney failure. Experts explain how the drug helps.

Axsome, FDA and migraine

Reuters · 11h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Business Insider · 13h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Seeking Alpha on MSN · 12h

Axsome gets FDA approval for Symbravo for migraine

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,

FDA upgrades recall of Lay's potato chips

USA Today · 1d

Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?

The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.

Fortune on MSN · 1d

FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’

The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.

Yahoo · 1d

Lay’s Potato Chip Recall Increased to Highest Risk Level, FDA Warns Product Could Cause 'Death’

Lay’s Classic Potato Chips due to “undeclared milk.” The affected chips were sold in Oregon and Washington. On Monday, Jan. 27, the FDA classified the issue as a Class 1 recall, which is defined as “a situation in which there is a reasonable probability that the use of,

14h

US FDA Identifies Cybersecurity Risks in Certain Patient Monitors

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...

1don MSN

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

1hon MSN

GE HealthCare Technologies Inc. (GEHC): FDA-Cleared AI Ultrasound Systems for Women’s Health

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at ...

Opinion

Williamsport Sun-Gazette2hOpinion

What other newspapers are saying: Pharmacy benefit practices must be reformed

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

2don MSN

Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears

Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been ...

Hosted on MSN42m

NY: The American Heart Association's Red Dress Collection Concert 2025 - Arrivals - 59179800

Sarah Drew attends The American Heart Association's Red Dress Collection Concert 2025 at Jazz at Lincoln Center, New York, NY ...

Crain's New York33m

NYU-backed startup seeks to bypass ophthalmologists with handheld eye scanner

AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Ozempic receives FDA nod for treating chronic kidney disease

Axsome, FDA and migraine

FDA upgrades recall of Lay's potato chips

Related topics